FWDI

Forward Industries, Inc. - 10-Q Summary (Q2 Fiscal 2008)

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2008 (the "2008 Quarter") and the six-month period ended March 31, 2008 (the "2008 Period"). Forward Industries, Inc. designs, markets, and distributes custom soft-sided carrying cases for portable electronic devices, primarily cellular phones and medical devices (blood glucose monitors). The company operates as a smaller reporting company with no long-term debt outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 20% ($1.15 million) in the quarter and 27% ($3.63 million) in the six-month period compared to the prior year. This was driven by an 85% decline in cell phone product sales, primarily due to reduced "in-box" orders from Motorola.
• Product Mix Shift: Diabetic product sales increased 13% in the quarter and 25% in the six-month period, now representing 75% of total revenue (up from 55% in the prior year quarter). However, these products carry narrower margins.
• Margin Compression: Gross margin dropped from 22% to 13% in the quarter. Contributing factors include the shift to lower-margin diabetic products, a $0.3 million charge for obsolete inventory (mostly Motorola-licensed goods), and rising costs of goods sold due to inflation and currency fluctuations in China.
• Operating Expenses: Total operating expenses decreased 15% in the quarter, largely due to reduced personnel costs following executive departures and lower royalty expenses post-license expiration.

Outlook, Risks, and Unusual Items

• Motorola License Expiration: The company's license to sell Motorola-branded products in the EMEA region expired on December 31, 2007. Sell-through rights for existing inventory expired March 30, 2008. Negotiations for a new agreement are ongoing but uncertain, especially following Motorola's announcement to spin off its Mobile Devices business.
• Inventory Obsolescence: The company recorded significant charges for obsolete inventory related to cell phone products held for the expired Motorola license. Inventory allowances increased to approximately $1.0 million.
• Key Personnel Event: Jerome E. Ball, Chairman of the Board and former CEO, died on April 22, 2008. The company anticipates a $100,000 termination benefit payment to his estate. Douglas W. Sabra was appointed Acting Chairman.
• Liquidity: The company maintains strong liquidity with $20.2 million in cash and no outstanding debt. A $3.0 million U.S. credit facility expired in March 2008 and was not renewed. A $400,000 uncommitted Swiss credit facility remains available but is partially encumbered by a letter of credit.
• Outlook: Management foresees continued weak operating results and potential net losses for Fiscal 2008 due to the steep decline in cell phone sales and the lack of imminent new "in-box" programs to replace lost revenue.

Investor Verification Checklist

• Motorola Renewal Status: Verify the current status of negotiations for a new license agreement with Motorola and the impact of the Mobile Devices spin-off on future orders.
• Customer Concentration: Confirm the stability of the top three customers (Lifescan, Abbott, Roche), which now account for a higher percentage of total revenue due to the collapse of cell phone sales.
• Inventory Valuation: Assess the adequacy of the $1.0 million inventory allowance and the risk of further write-downs on custom-made goods held for OEM hubs.
• Cost Pressures: Monitor the ability to pass on rising labor, material, and currency costs from Chinese suppliers to customers.
• Succession Planning: Evaluate the impact of the Chairman's death and the transition of leadership on strategic direction and key customer relationships.